Financial statements Biofol
Company suspended its operations from 2025-11-01
Balance sheet data of BIOFOL
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 58 949,00 | 275 240,79 | 464 004,61 | 887 389,19 | 502 474,88 | 495 764,25 |
| A. Fixed assets | 21 625,00 | 76 912,46 | 57 987,46 | 64 633,13 | 38 171,67 | 7 867,17 |
| B. Current assets | 37 324,97 | 198 328,33 | 406 017,15 | 822 756,06 | 464 303,21 | 487 897,08 |
| C. Share capital contributions (basic funds) | - | - | - | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | - | 0,00 | 0,00 |
| Total liabilities | 58 949,97 | 275 240,79 | 464 004,61 | 887 389,19 | 502 474,88 | 495 764,25 |
| A. Equity | 58 580,97 | 220 801,51 | 300 923,79 | 310 536,87 | 130 569,27 | 106 731,74 |
| B. Liabilities and provisions for liabilities | 369,00 | 54 439,28 | 163 080,82 | 576 852,32 | 371 905,61 | 389 032,51 |
| I. Long-term liabilities | - | - | 0,00 | - | - | - |
| II. Short-term liabilities | 369,00 | 54 439,28 | 163 080,82 | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.